Recently proposed changes from federal regulators have ambulatory surgery center (ASC) executives feeling good about 2026. Tenet Healthcare Corp. (NYSE: THC) leaders said on Tuesday that proposed federal changes to the Medicare Inpatient Only (IPO) list could further strengthen the company’s ASC business, particularly in higher-acuity specialties like orthopedics and spine, for instance. “You know, we’ve seen higher acuity, good case mix, good payer mix, good growth in some of our key case lines, service lines, including ortho and total joints,” CFO Sun Park said on Tenet’s 2025 second-quarter earnings call. “That’s why you saw the strong net revenue overall growth of 7.7% as well as a strong net revenue per case.”
Read the full article: Tenet CEO Saum Sutaria: CMS Enabling ASC Innovation Will Be Big Positive for USPI //
Source: https://ascnews.com/2025/07/tenet-ceo-saum-sutaria-cms-enabling-asc-innovation-will-be-big-positive-for-uspi/